Premium
MRI‐Based Measurement of Brain Stem Cross‐Sectional Area in Relapsing‐Remitting Multiple Sclerosis
Author(s) -
Chivers Tomos R.,
Constantinescu Cris S.,
Tench Christopher R.
Publication year - 2015
Publication title -
journal of neuroimaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.822
H-Index - 64
eISSN - 1552-6569
pISSN - 1051-2284
DOI - 10.1111/jon.12244
Subject(s) - pons , medicine , medulla oblongata , multiple sclerosis , atrophy , magnetic resonance imaging , midbrain , medulla , spinal cord , nuclear medicine , pathology , brain size , anatomy , radiology , central nervous system , psychiatry
PURPOSE To determine if patients with relapsing‐remitting multiple sclerosis (RRMS) have a reduced brain stem cross‐sectional area (CSA) compared to age‐ and sex‐matched controls. The brain stem is a common site of involvement in MS. However, relatively few imaging studies have investigated brain stem atrophy. METHODS Brain magnetic resonance imaging (MRI) was performed on patients and controls using a 1.5T MRI scanner with a quadrature head coil. Three‐dimensional magnetization‐prepared rapid acquisition gradient‐echo (MPRAGE) images with 128 contiguous slices, covering the whole brain and brain stem and a T2‐weighted image with 3 mm transverse contiguous images were acquired. We measured the brain stem CSA at three sites, the midbrain, the pons, and the medulla oblongata in 35 RRMS patients and 35 controls using a semiautomated algorithm. CSA readings were normalized using the total external cranial volume to reduce normal population variance and increase statistical power. RESULTS A significant CSA reduction was found in the midbrain ( P ≤ .001), pons ( P ≤ .001), and the medulla oblongata ( P = .047) postnormalization. A CSA reduction of 9.3% was found in the midbrain, 8.7% in the pons, and 6.5% in the medulla oblongata. CONCLUSIONS A significantly reduced, normalized brain stem CSA was detected in all areas of the brain stem of the RRMS patients, when compared to age‐ and gender‐matched controls. Lack of detectable upper cervical cord atrophy in the same patients suggests some independence of the MS pathology in these regions.